Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Cell therapy is promising in treating psychiatric disorders, such as depression. -- A proof-of-principle study published in "Cell Stem Cell" by the laboratory of Dr. Chen, founder of UniXell Biotech, suggests this. 2025-08-20 20:49
Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from FDA 2025-08-19 22:00
WuXi Biologics Reports Solid 2025 Interim Results 2025-08-19 20:35
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC 2025-08-19 20:09
Nilesh Shah joins Illumina as Head of Region, AMEA 2025-08-19 14:14
Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma 2025-08-19 13:26
Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease 2025-08-19 11:00
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries 2025-08-19 08:00
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP). 2025-08-18 21:00
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company 2025-08-18 20:00
KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS 2025-08-18 18:29
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies 2025-08-18 12:40
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity 2025-08-18 08:15
GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation 2025-08-17 20:01
Novel Gene Therapy for ALS cleared for global trials in China and the U.S. 2025-08-15 19:00
CARsgen Therapeutics Announces 2025 Interim Results 2025-08-15 08:15
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to Severely Active Ulcerative Colitis 2025-08-14 12:02
BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan 2025-08-13 20:00
Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform 2025-08-13 15:36
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration 2025-08-13 09:44